How do we determine whether Simmons First National Corporation (NASDAQ:SFNC) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data shows that their consensus long positions have historically outperformed the market when we adjust for known risk factors.
Simmons First National Corporation (NASDAQ:SFNC) was in 5 hedge funds’ portfolios at the end of the third quarter of 2015. SFNC investors should be aware of a decrease in hedge fund sentiment in recent months. There were 8 hedge funds in our database with SFNC positions at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Select Medical Holdings Corporation (NYSE:SEM), Prothena Corporation PLC (NASDAQ:PRTA), and Third Point Reinsurance Ltd (NYSE:TPRE) to gather more data points.
Now, let’s review the latest action encompassing Simmons First National Corporation (NASDAQ:SFNC).
How are hedge funds trading Simmons First National Corporation (NASDAQ:SFNC)?
At Q3’s end, a total of 5 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -38% from the previous quarter. With hedgies’ sentiment swirling, there exists a select group of key hedge fund managers who were boosting their stakes meaningfully (or already accumulated large positions).
According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Jim Simons’ Renaissance Technologies has the number one position in Simmons First National Corporation (NASDAQ:SFNC), worth close to $5.5 million, comprising less than 0.1% of its total 13F portfolio. Sitting at the No. 2 spot is Ken Gray and Steve Walsh of Bryn Mawr Capital, with a $2.3 million position; 0.4% of its 13F portfolio is allocated to the stock. Other members of the smart money that are bullish include Sharif Siddiqui’s Alpenglow Capital, Matthew Tewksbury’s Stevens Capital Management and Ken Griffin’s Citadel Investment Group.